10-K/A XBRL

FORM 10-K/A

Company: Nuvectis Pharma, Inc.
Filed: March 27, 2023
Period of Report: December 31, 2022
Accession Number: 0001104659-23-036896

View Document ↗ View on SEC.gov ↗